Amazing presentation by @rociovacikdiaz.bsky.social at European Congress on Thrombosis and Haemostasis (ECTH) 2025: impact of LVAD implantation on circulating proteome with a focus on the early dynamic changes. Work from Team 2 led by Professor @sophiesusen.bsky.social , UMR1011

Congratulations to @melaniedaniel.bsky.social MD at CHU de Lille and at UMR1011 team 2, led by Pr @sophiesusen.bsky.social) for her great presentation at the European Congress on Thrombosis and Haemostasis : “Unbiased assessment of VWD burden and healthcare consumption using pseudonymized big data.”

Congrats to @mickaelrosa.bsky.social and Pr Antoine Rauch on winning the Bernd R. Binder publication prize at ECTH for their 2023 paper : role of ECMO-associated shear forces on GPIba shedding resulting in platelet clearance and thrombocytopenia. Team 2 Pr @sophiesusen.bsky.social, UMR1011

Wonderful presentation by @mickaelrosa.bsky.social in the Science Fast and Furious session at ECTH2025 in Prague : effect of emicizumab focusing on monocytes/macrophages using single cell and transcriptomic data. Work from team 2 led by Professor @sophiesusen.bsky.social, UMR1011.

We are honored to welcome @riittalassila.bsky.social to Paris for the French Society of Hematology's talk on Red Blood Cells in Hemostasis. Thank you! #sfh #sfth #hemsky #hemesky

Plenary session at the SFH with Prof. Marie-Christine Alessi invited for a talk on phenotype/genotype in platelet disorders with Hana Raslova as moderator. #hemesky #hemsky #sfh

Maladies cardiovasculaires : un médicament à l’essai pour prévenir de la sténose aortique 👇 Lire le communiqué : presse.inserm.fr/maladies-car... @chulille.bsky.social @univlille.bsky.social

🔬 Sténose aortique : un traitement médicamenteux ? L’équipe des Prs Susen et Van Belle a identifié une nouvelle piste thérapeutique : l’acide rétinoïque, qui pourrait ralentir la calcification de la valve aortique. Ce médicament offrirait une alternative au remplacement valvulaire 🫀.

@sfthemostase.bsky.social

Science News@scinews.bsky.social · 2y ago

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose blood thinners. #NEJM www.nejm.org/doi/full/10....

Very proud to be invited to the RFHT journal for the Year of hemostasis. Was an amazing experience. #rfht

La Société Française de Thrombose et d’Hémostase (SFTH) est désormais sur Bluesky ! 🌟 Rejoignez-nous pour échanger autour de l’hémostase, de la thrombose et de l’innovation scientifique. Suivez-nous pour rester informés de nos actualités et événements ! 🩸💬 #SFTH #Thrombose #Hémostase #Medsky

www.inserm.fr/portrait/lau...

www.inserm.fr/portrait/lau...

www.inserm.fr/portrait/lau...

First manuscript of my PhD student Blandine Gendre. New molecular player in factor V regulation identified by a underestimated statistical method for GWAS data

bioRxiv Genetics@biorxiv-genetic.bsky.social · 3y ago

A genome wide search for non-additive allele effects identifies PSKH2 as involved in the variability of Factor V activity. https://www.biorxiv.org/content/10.1101/2024.02.08.579474v1

Welcome NEW followers! Let's build a great community together! Am a Dutch platelet biologist in Sydney, interested in science communication, extracellular vesicles and glycans. In my spare time, I am in nature, taking pictures of birds 😄

Dianne@dianvanderwaldr.bsky.social · 2y ago

Hi everyone, 👋 so good to see many old friends here! This is me in a nutshell 😊

Every year, we have a great meeting during two days for our Société Française de Thrombose et d'Hémostase #sfth #Hemsky @sophiesusen.bsky.social @chloejamesbdx.bsky.social

Hello BlueSky community! Please follow our account to stay updated on the latest thrombosis and hemostasis research! #MedSky #HemeSky #Thrombosis #Hemostasis #Hematology #JTHJournal